Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-005614
Filing Date
2025-08-08
Accepted
2025-08-08 16:45:55
Documents
45
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q celz_10q.htm   iXBRL 10-Q 599976
2 CERTIFICATION celz_ex311.htm EX-31.1 15231
3 CERTIFICATION celz_ex312.htm EX-31.2 15084
4 CERTIFICATION celz_ex321.htm EX-32.1 6544
5 CERTIFICATION celz_ex322.htm EX-32.2 5578
11 celz_10qimg2.jpg GRAPHIC 49805
  Complete submission text file 0001477932-25-005614.txt   3008582

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celz-20250630.xsd EX-101.SCH 29582
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20250630_lab.xml EX-101.LAB 197105
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20250630_cal.xml EX-101.CAL 30366
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20250630_pre.xml EX-101.PRE 158623
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20250630_def.xml EX-101.DEF 84802
48 EXTRACTED XBRL INSTANCE DOCUMENT celz_10q_htm.xml XML 296392
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)